baber/WOPTO huggingface dataset:
Patent PT-760710-E (PT)
Inventor: RASANEN PENTTI
IPC: B30B1/00
Filed: 1993-12-21
Abstract: PCT No. PCT/FI93/00549 Sec. 371 Date May 17, 1995 Sec. 102(e) Date May 17, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/14539 PCT Pub. Date Jul. 7, 1994An apparatus for lifting and dropping a drop hammer in a crushing or compaction process allows the drop hammer to fall completely freely, without being retarded by an attached cable or other element, and allows the height to which the hammer is lifted to be infinitely adjusted, i.e. to virtually any position. The drop hammer moves vertically, up and down, within a hollow cylinder and has a latch engaging head on an upper portion. An anchoring device is disposed within the cylinder and is distinct from the drop hammer and cylinder, and includes first and second latches which are movable by an actuator (such as a hydraulic cylinder) to engage or disengage the drop hammer head. The latches are typically mounted between top and bottom generally horizontal plates, and are pivotally connected adjacent one end to the plates and adjacent another end to the actuator. Crank blocks and a synchronizing lever may be provided. At least one cable connected to a pulley or winch at the top of the cylinder moves the anchoring device up and down, and one or more hydraulic hoses feeding the actuator (where a hydraulic cylinder) may be reeled separately from the cable.
Patent PT-732962-E (PT)
Inventor: PAULUS JOSEPH A
IPC: A61F7/00
Filed: 1994-12-07
Abstract: A COPd thermoseed for treating cancerous tissue. The alloy constituents are chosen such that the Curie point temperature thereof falls into a therapeutic range. Because its magnetization vs. temperature characteristic exhibits an increasing slope up to the Curie transition, thermoseeds fabricated from the alloy can be optimized about the maximum in the M-T curve.
Patent PT-742708-E (PT)
Inventor: HIRSCH WILLIAM HENRY
IPC: A61M25/00
Filed: 1995-01-26
Abstract: An improved gastrostomy tube is a flexible tube having on one inner end thereof an improved energy absorbent internal retaining member which provides for less patient trauma during emplacement and subsequent percutaneous removal, while almost entirely avoiding either separation of the internal retaining member, i.e., the bumper, or its acute displacement. The energy absorbing internal retaining member has a hollow body portion with two resiliently reversible physical forms or shapes, toroidal-like, and, goblet-like connected to a foreshortened hollow axial stem portion that is attached to or integrally made with the inward end of the flexible tube. The internal retaining member is made in the toroidal-like form. During intentional removal, when under pressure against the stomach mucosa, the internal retaining member snaps into the unrolled, goblet-like shape and pulls smoothly out through the stoma tract.
Patent PT-777490-E (PT)
Inventor: CLEMENTS JOHN D
IPC: A61K39/108
Filed: 1995-07-18
Abstract: Methods and compositions are provided herein for the use of a novel mutant form of E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity. This enterotoxin is used in combination with an unrelated antigen to achieve an increased immune response to said antigen when administered as part of an oral vaccine preparation.
Patent PT-734318-E (PT)
Inventor: JORDAN ERICH G
IPC: B29C48/08
Filed: 1995-10-13
Abstract: Electrically conductive tape yarns of two or more layers comprising thermoplastic polymer resin and electrically conductive particles are prepared by a process comprising extruding a multilayer film containing at least one electrically conductive layer and at least one layer substantially free of electrically conductive particles, quenching the film, slitting the film into tapes and orienting the film before or after slitting.
Patent PT-866792-E (PT)
Inventor: BAUER CHRISTOPHE
IPC: C07D405/12
Filed: 1996-12-12
Abstract: A crystalline polymorphous terazosine monohydrochloride is obtained by suspending and treating a crystalline addition product of terazosine hydrochloride and methanol in a polar solvent which is an alcohol with 2 to 6 carbon atoms or a ketone with 2 to 6 carbon atoms or a mixture thereof. The thus obtained crystalline polymorphous terazosine hydrochloride is characterized by a reduced hygroscopicity and solvent residue retention capacity.
Patent PT-816288-E (PT)
Inventor: RUDOLPH WERNER
IPC: C01D15/00
Filed: 1997-06-18
Abstract: Production of lithium hexa-fluoro-metallates of formula: LiMF6 (where M = P or As) comprises forming a reaction product by reacting MX3 (where M = as above and X = F, Cl, or Br) with elemental Cl, Br or I and HF, and contacting the reaction product on or after its formation with lithium halide.
Patent PT-904392-E (PT)
Inventor: KINGSMAN ALAN JOHN
IPC: C12N15/09
Filed: 1997-10-17
Abstract: A lentivirus-derived, replication defective vector particle for gene therapy, said vector particle being capable of infecting and transducing non-dividing mammalian target cells, said vector particle comprising the RNA genome of the vector, gag and pol proteins and an env protein or a functional substitute therefor. <IMAGE>
Patent PT-925568-E (PT)
Title: Man-machine interface for airport traffic control
Inventor: CASTOR ROBERT
IPC: G06F3/033
Filed: 1997-08-29
Abstract: Man-machine interface (MMI) for airport traffic control purposes, in particular for safe taxiing and/or approach-departure control at an airport, having a display area on which processes and states at the airport, for example the movements and the current position of aircraft, the switching state of lighting systems, etc., can be displayed and influenced. The display area is designed with a screen whose diagonal is more than 19 inches, preferably more than 21 inches.
Patent PT-1023184-E (PT)
Inventor: HARRISON PAUL W
IPC: G06K1/12
Filed: 1998-09-08
Abstract: A method of laser marking metals, plastics, ceramic materials, glazes, glass ceramics, and glasses of any desired form, which includes applying to the material to be marked a variable thickness layer of marking material containing energy absorbing enhancers then irradiating said layer with a laser or diode based energy source such that the radiation is directed onto said layer in accordance with the form of the marking to be applied, and using a laser or diode based energy source of a wavelength which is sufficiently absorbed by the marking material so as to create a bonding of the marking material to the surface of the workpiece at the irradiated areas.
Patent CA-2785203-F (CA)
Title: Apparatus for cleaning industrial components
Inventor: PHILLIPS WILLIAM LASH
IPC: B08B3/12
Filed: 2010-12-22
Granted: 2011-06-30
Abstract: An apparatus for cleaning industrial components has a liquid container defining a liquid enclosure for containing a cleaning liquid and ultrasonic transducers having an operating frequency and a wavelength in the cleaning liquid and secured to at least a portion of the liquid container at a spacing of between 2 and 10 wavelengths. In operation, the transducers generate a larger power density in the component-receiving area of the liquid container than an average power density of the liquid container.
Patent IE-880147-L (IE)
Title: T-shaped branch pipe connector
IPC: F16L37/00
Filed: 1988-01-21
Abstract: A pipe connecting piece for drainage pipes consists of a main part (1) and at least one branch part (2) connected thereto so that the pipe connecting piece is essentially T-shaped. The main part (1)is provided with an opening (3), disposed in the wall, which is bounded at the circumference by a part of the wall of the main part which is bent outwards in the form of a collar (4). The branch part (2) fits into said collar and is secured therein by means of a number of inwardly directed bulges (5) disposed in the circumferential wall of the collar (4) and the wall section of the branch part (2) fitted therein. The pipe connecting piece easy to manufacture without expensive tools and without use of glue joints.
Patent IE-35256-L (IE)
Title: Magnetic recording and reproducing apparatus
IPC: G11B25/06
Filed: 1971-02-12
Abstract: A magnetic recording and reproducing apparatus of the type having a tape guide drum and at least one rotary head to scan a tape wrapped on the drum is provided with a device for automatically wrapping the tape on the guide drum, for example, from a cassette or cartridge containing the tape. Such device has a rotatable support, in the form of a ring, extending around the drum and carrying guides, and a tape engaging member also mounted on the ring and being movable into and out of a guide path spaced from the drum and defined by the guides. The tape engaging member, in an inactive condition of the apparatus, is displaced out of the guide path to engage the tape in the cassette or cartridge, and is moved into the guide path upon turning of the ring to draw a loop of the tape from the cassette or cartridge and to wrap one side of the loop about the guide drum while the other side of the loop is engaged by the guides and maintained in the corresponding guide path.
[US3740495A]
Patent IE-40875-L (IE)
Title: 7 ß-ACYLAMINO -7Ó- ALKOXYCEPHALOSPORINS AND 6ß-ACYLAMINO¹-6Ó- ALKOXYPENICILLINS
IPC: C07D499/21
Filed: 1975-03-21
Abstract: A process for preparing a 7 beta -acylamino-7 alpha alkoxycephalosporin or 6 beta -acylamino-6 alpha -alkoxypenicillin which comprises either (a) reacting a 7 beta -( alpha '-halogeno or alpha '-hydroxyacylamino)cephalosporin or 6 beta -( alpha 'halogeno or alpha '-hydroxyacylamino)penicillin with a halogenating agent to give a alpha -halogeno-iminohalide, reacting the latter compound with an equimolar amount of an alkali metal alkoxide in the presence of one equivalent amount of a base to give a 7 alpha -alkoxyketeneimine and subjecting the latter compound to hydration; or (b) reacting the 7 beta -( alpha '-halogeno or alpha 'hydroxyacylamino)cephalosporin or 6 beta -( alpha '-halogeno or alpha '-hydroxyacylamino) penicillin with the halogenating agent to give the alpha -halogeno-iminohalide, reacting the latter compound with two equimolar amounts of the alkali metal alkoxide in the presence of one equivalent amount of the base to give a dialkoxyimino compound, reacting the latter compound with a halogeno-silyl compound or an acid and treating the resulting product with water.
[US3960845A]
Patent IE-41226-L (IE)
Title: Benzylamines; pharmaceutical compositions
IPC: A61K31/135
Filed: 1975-04-03
Abstract: 1463965 Compositions containing benzylamines DR KARL THOMAE GmbH 2 April 1975 [3 April 1974] 13466/75 Heading A5B Pharmaceutical compositions in the form of dosage units comprise as active ingredient at least one compound of the general formula: wherein Hal represents Cl or Br; R1 represents H, Cl or Br; R2 represents a C3 to C5 branched alkyl group optionally substituted by from 1 to 3 hydroxyl groups or represents a cyclohexyl or hydroxycyclohexyl group; and R4 represents a straight-chain or branched alkyl group containing 1 to 4 carbons or (if R2 represents a C3 to C5 branched alkyl group optionally substituted by from 1 to 3 hydroxyl groups or represents a hydroxycyclohexyl group), a hydrogen atom, or a physiologically compatible acid addition salt thereof, an association with a pharmaceutical carrier or excipient, each dosage unit containing from 25 to 100 mg of active ingredient.
[GB1463965A]
Patent IE-810915-L (IE)
Title: Telecommunications switching network
IPC: H04Q11/08
Filed: 1981-04-23
Abstract: It has been proposed to base advanced Digital Switching networks on a modular array using Digital Switch Modules (DSM). It has been found, for large traffic handling Digital switching systems, that the cross-office delay encountered in multi-stage networks based on 8x8 Digital Switching Modules (DSM's) is unacceptably large. To maintain the flexibility provided by the multi-stage concepts a demultiplexing/mixing/remultiplexing stage (DMR) is introduced to replace intermediate DSM ranks. The DMR is used to provide a preset time/space switching function within the total trunking providing the availability of a controlled stage but without the control and delay penalties associated with a fully flexible DSM or the control and link blocking disadvantages associated with a pure space switch. The DMR effectively acts as a pre-programmed or counter driven DSM. By adjusting the degree of DMR function it is possible to provide a very wide range of switch sizes which uses a common organization in the controlled switch stages. The operation of the DMR may be defined in conjuction with a mirror imaging correlation function to provide a constant switch loop delay for duplex connections.
[US4425640A]
Patent FI-821288-L (FI)
Inventor: WICK ALEXANDER
IPC: C07D211/14
Filed: 1982-04-13
Abstract: Phenethanolamine derivatives in the (+)-erythro form of the formula: <IMAGE>   wherein X represents a halogen atom, are new compounds useful in therapy.
Patent FI-824503-L (FI)
Inventor: CEINTREY CLAUDE
IPC: G03C7/14
Filed: 1982-12-29
Abstract: PCT No. PCT/FR81/00151 Sec. 371 Date Jul. 30, 1982 Sec. 102(e) Date Jul. 30, 1982 PCT Filed Nov. 19, 1981 PCT Pub. No. WO82/01944 PCT Pub. Date Jun. 10, 1982.The invention relates to new diazotype materials of which the sensitive layer contains, as a base generator, a compound comprising a basic part and an acid part, the acid part being a 2-carboxycarboxamide group and the basic part consisting of an alkali metal cation or alkaline earth metal cation or a tetraalkylammonium cation. These diazotype materials develop rapidly and possess an excellent resistance to ageing.
Patent IE-35762-L (IE)
Title: Hot gas defrost refrigeration system
IPC: F25B5/00
Filed: 1971-10-20
Abstract: 1316930 Refrigerating; defrosting PET Inc 28 Oct 1971 [30 Oct 1970] 50242/71 Heading F4H A compression refrigeration system comprises a plurality of evaporators 21 ... 24 which are selectively defrosted by a hot gas flow from the compressor 10 after interruption of the normal compressor flow to the condenser 14 by means of a solenoid valve 32 and a differential valve 34 in the high pressure side between the compressor and condenser to create a pressure differential in the system upstream of the liquid refrigerant receiver 17. This pressure differential promotes hot gas flow through any one or more of the evaporators, e.g. 23 and 24, and the resultant liquid refrigerant is passed via conduits 35, one way valves 36 and a common condensate header 37 back to the high pressure side of the system. The header 37 may be connected to the high pressure side of the system between the differential valve 34 and condenser, to a liquid-vapour separator, or between the condenser and receiver.
[GB1316930A]
Patent IE-821645-L (IE)
Title: Preparation of penam compounds
IPC: C07D499/04
Filed: 1982-07-08
Abstract: A process for the preparation of a penam derivative of formula (I): <IMAGE> (I)  wherein RA is hydrogen or a group of formula (Ia): <IMAGE> (Ia)  wherein X is -CO2R1, or SO3R1; R is C1-6alkyl, aryl, or heterocyclyl; R1 is hydrogen, or a pharmaceutically acceptable salt-forming ion or ester-forming radical, and R2 represents hydrogen or a pharmaceutically acceptable salt-forming ion or in vivo hydrolyzable ester-forming radical; which process comprises reacting a compound of formula (II):    <IMAGE> (II)  wherein RB is hydrogen, a removable amino blocking group, or a group of formula (IIa): <IMAGE> (IIa)  wherein Y is -CO2Rx or -SO3Rx; R is as defined with respect to formula (I) above; Rx represents an ester-forming radical, RY represents hydrogen, a salt-forming radical or a carboxyl-blocking group, and R3 represents an alkyl, benzyl, or aryl group; with methanol in the presence of copper ions; and thereafter if necessary carrying out one or more of the following steps: (i) removal of any blocking group; (ii) converting the product to a pharmaceutically acceptable salt or ester thereof.
Patent IE-801914-L (IE)
Title: Paracetamol compositions
IPC: A61K31/165
Filed: 1980-09-12
Abstract: The acute liver toxicity effects of paracetamol are reduced by co-formulating with sustained release ascorbic acid which produces high liver concentrations of ascorbate anion after oral administration of the co-formulation. A suitable form of sustained release ascorbic acid is prepared by microencapsulation of particles of ascorbic acid in membranes which act as microdialysis cells.
[US4292298A]
Patent IE-851932-L (IE)
Title: 2,5-pyrrolidinedione derivatives
IPC: C07D207/40
Filed: 1985-08-02
Abstract: This invention encompasses compounds of the formulaand pharmaceutically acceptable acid addition salts thereof wherein n is 2 or 3 and R and R, are n-propyl, isopropyl, or R, and R, together with N form a 2,6-dimethyl-1-piperidinyl group. The compounds of this invention are useful as antiarrhythmic agents.
Patent IE-802151-L (IE)
Title: Semiconductors
IPC: H01L21/265
Filed: 1980-10-16
Abstract: A process for annealing crystal damage in ion implanted semiconductor devices in which the device is rapidly heated to a temperature between 450 DEG and 900 DEG C. and allowed to cool. It has been found that such heating of the device to these relatively low temperatures results in rapid annealing. In one application the device (17) may be heated on a graphite element (14) mounted between electrodes (15) in an inert atmosphere in a chamber (11). The process may be enhanced by the application of optical radiation from a Xenon lamp (19).
[US4350537A]
Patent IE-782476-L (IE)
Title: Quinolinylaminofluorobenzoic acid derivatives
IPC: C07D215/44
Filed: 1978-12-14
Abstract: Derivatives of 2-(4-quinolinylamino)-5-fluorobenzoic acid compounds of the formula <IMAGE> I wherein X is selected from the group consisting of chlorine and -CF3 in the 7- or 8-position and R is selected from the group consisting of hydrogen, an esterifying group, alkali metals, alkaline earth metals, ammonium and non-toxic, pharmaceutically acceptable organic amines and their non-toxic, pharmaceutically acceptable acid addition salts having remarkable analgesic properties and their preparation.
[US4233305A]
Patent IE-832542-L (IE)
Title: Leukocyte interferon preparations
IPC: C12P21/02
Filed: 1983-10-28
Abstract: A method of removing oligomers and slow monomer from leukocute interferon (IFN- alpha ) having high sequence homology with human leukocyte interferon which method comprises:
 a) incubating a buffer solution containing 1-20 mg/ml of IFN- alpha  at a pH between 3 and approximately 4.8 for 30 minutes-24 hours at 28-40 DEG C to precipitate oligomers and slow monomer followed by;
 b) recovering native IFN- alpha .
Patent IE-842597-L (IE)
Title: Pharmaceutical pack and method
IPC: A61K31/565
Filed: 1984-10-11
Abstract: A pharmaceutical composition containing a prostaglandin and an antigestagen is suitable for induction of labor and for abortion.
Patent IE-873353-L (IE)
Title: Colour-coding of data carriers
IPC: G06K1/12
Filed: 1987-12-10
Abstract: The present is a description of a method for color coding data carriers, such as labels, which comprise a substrate onto which several color code segments of various colorations have been deposited. In a programme controlled process it is possible to render the coloration of each individual color code segment unidentifiable so that the combination of the remaining color code segments yield the desired color code. In this way it is possible to carry out color coding using a single-color printer for instance.
Patent IE-893974-L (IE)
Title: PROTOTYPE FeLV ISOLATES FOR USE IN DISEASE MODELS AND¹VACCINES
IPC: A61P31/18
Filed: 1989-12-12
Abstract: Molecular clones of feline leukemia virus isolates that encode (a) a prototype highly infectious, minimally pathogenic virus, (b) a variant genome that is replication-defective and associated with a fatal immunodeficiency in cats similar to AIDS (FAIDS) or (c) a chimeric genome that is replication-competent and induces FAIDS. These molecular clones may be used to generate cell lines producing infectious virus which is useful in the preparation of vaccines or in the generation of viremia or disease challenge systems.
Patent IE-960911-L (IE)
Title: Acidinium derivatives and their use in luminescence¹immunoassays
IPC: G01N33/533
Filed: 1987-08-21
Abstract: The invention relates to novel acridinium derivatives of the formula I: <IMAGE> in which R<1> is hydrogen, an alkyl, alkenyl or alkynyl radical having 1 to 10 carbon atoms, a benzyl or aryl group, R<2> and R<3> are hydrogen, an alkyl group having 1 to 4 carbon atoms, a substituted or unsubstituted amino group, a carboxyl, C1-C4-alkoxy, cyano or nitro group or halogen, R<4> is a radical in which a sulphonamide group is bonded directly to the carbonyl group via the nitrogen and A<(-)> is an anion which does not interfere with the chemiluminescence; and their use in luminescence immunoassays.
Patent NO-803841-L (NO)
Inventor: GRAF RICHARD
IPC: D06F35/00
Filed: 1980-12-17
Abstract: 1. Method for rinsing of laundry washed by a wasker program-controlled and rinsed in several rinsing cycles in succession depending on output of a measuring epuipment testing the dirt-percentage of the rinsing water, and controlling the program-control-unit to finish the program flow if a dirt-percentage has obtained a fixed admissible value, characterized in that the measuring equipment (M) will be activated on the end of each rinsing cycle for a defined period of time, which is characterized by the moving of the washing drum and the following pump-off of the rinsing solution, and in that for finishing the program the program-control-unit is adjusted to skip instructions until the pump-off instruction before the least rinsing cycle.
Patent NO-811955-L (NO)
Inventor: LASZLO TOMAS PABLO NICOLAS
IPC: A01N59/12
Filed: 1981-06-10
Abstract: A foamed plastic and a method for its production are described. Tne foamed plastic has cavities which consist of open cells or pores. In at least a portion of the cavities, particles of water-insoluble hydrophilic polymer are homogeneously distributed, the particles being swellable to a gel in water. Examples of such polymer particles are granules of cross-linked dextran. The polymer particles are incorporated in the foamed plastic by being suspended in a liquid impregnating agent, such as ethanol-chloroform which is of substantially the same density as the polymer particles. A water-soluble binder, such as polyvinyl pyrrolidone, is also dissolved in the impregnating agent, and suitably also a plasticizing and surface active agent, such as a poloxamer. The foamed plastic is impregnated with the liquid suspension, whereafter the impregnating liquid is removed by drying. The polymer particles are anchored to the dried foamed plastic by means of the binder, whereas the polymer particles, on use of the foamed plastic product for, for example, treating a running sore, swell to form a gel such that they fill out the cavities of the foamed plastic and are retained because of steric hindrance. The foamed plastic product is int.al. usable as a bandage and/or for plugging to drain exudate from injured skin surfaces, such as running sores, and in the treatment of incontinence. Also non-clinical fields of use, such as the use of gel iodophore-provided foamed plastic for water purification, are included in the invention.
Patent NO-832102-L (NO)
Inventor: FORSE SIDNEY FENTON
IPC: A23G3/28
Filed: 1983-06-09
Abstract: Coloured intagliated articles, for example coloured intagliated pharmaceutical tablets, on which the intagliations are highlighted. The articles are coloured intagliated articles bearing a layer consisting essentially of a defined optically anisotropic substance, for example magnesium carbonate. Process for manufacturing said articles.